Inaktiver Wert

Andere Sprachen Can-Fite BioPharma Ltd. TEL AVIV STOCK EXCHANGE

Aktien

CANF

IL0010944739

CANF

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Can Fite BioPharma : Fite Presentation	08.07.
Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson	01.07.
Can-Fite BioPharma Ltd. Announces Improvement in Patient with Decompensated Liver Cirrhosis Upon Treatment with Namodenoson	01.07.
Can Fite BioPharma : Other Report or Announcement	28.06.
Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Can-Fite’s Partner Vetbiolix	28.06.
Can-Fite BioPharma Ltd. Announces Positive Results from Osteoarthritis Clinical Study in Dogs Reported by Vetbiolix	28.06.
Can Fite BioPharma : Other Report or Announcement	26.06.
Can Fite BioPharma : Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver	24.06.
Can-Fite Announces Breakthrough Findings Demonstrate Namodenoson Anti-Cancer and Protective Effect Mechanism in the Liver	24.06.
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver	24.06.
Can Fite BioPharma : Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study	10.06.
Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study	10.06.
Can-Fite Biopharma Ltd. Receives IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study	10.06.
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study	05.06.
Can-Fite Biopharma Ltd. Updates on Its Advanced Liver Cancer Pivotal Phase 3 Study	05.06.
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases	29.05.
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024	27.05.
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6	23.05.
Can Fite BioPharma : Immediate Report of Meeting	22.05.
Can Fite BioPharma : NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	22.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Can-Fite BioPharma Ltd. TEL AVIV STOCK EXCHANGE

Aktien

CANF

IL0010944739

CANF

Andere Sprachen

Filter